Analyst Ratings for Adeptus Biotechnologies Corp. (ADPT)
ADPT Rating Summary
ADPT Price Target Summary
- Highest: $14.00 (Piper Sandler)
- Lowest: $5.00 (Goldman Sachs)
- Average: $8.86
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$8.86 (+175.9%)
* Over Last 12-Mos
Rating Score: 6.9 / 10 Percentile Rank: 75%
Rating Score: 6.9 / 10 Percentile Rank: 75%
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
7/5/2023 | JPMorgan » Updated 2/15/2024 |
Rachel Vatnsdal | New Coverage | Overweight (N/A) |
8.00 (11.00) |
6.71 (3.21) |
-52.16% | Details |
1/5/2023 | Scotiabank » Updated 11/16/2023 |
Sung Ji Nam | New Coverage | Sector Outperform (N/A) |
10.00 (15.00) |
7.80 (3.21) |
-58.85% | Details |